3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Thyroid Nodule
5
Prostatic Neoplasms
5
Carcinoma, Hepatocellular
4
Thyroid Neoplasms
3
Thyroid Cancer, Papillary
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Melanoma
2
Uterine Cervical Dysplasia
1
Urinary Bladder, Neurogenic
1
Urinary Bladder Neoplasms
1
Spinal Dysraphism
1
Spinal Cord Compression
1
Recurrence
1
Prostatic Hyperplasia
1
Papillomavirus Infections
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Hypospadias
1
Hyperthyroidism
1
Gastrointestinal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Bevacizumab
17
Capecitabine
13
Cetuximab
10
Oxaliplatin
8
Irinotecan
8
Fluorouracil
7
Panitumumab
5
Leucovorin
4
trifluridine tipiracil drug combination
3
sintilimab
3
regorafenib
3
Nivolumab
3
Ipilimumab
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Folfox protocol
2
Drug Therapy
2
spartalizumab
1
pembrolizumab
1
irinotecan sucrosofate
1
glucopyranosyl lipid-A
1
folfirinox
1
camrelizumab
1
balstilimab
1
anisodamine
1
aflibercept
1
XELOX
1
Vemurafenib
1
Tyrosine Kinase Inhibitors
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colorectal Cancer Metastatic
×
Transurethral Resection of Prostate
×
Clear all
NCT05129787
2026-02-12
NEW-COMET
Oslo University Hospital
Phase NA
Active not recruiting
230 enrolled